为正生物 (839355.OC)

+ 收藏

现金流量表(为正生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 20,669,661.6415,346,783.1716,788,679.58396,856,496.48256,704,796.30
 收到的税费返还(元) 71.32921,098.92232,110.6411,478,768.495,009,662.02
 收到其他与经营活动有关的现金(元) 3,096,177.195,647,740.672,270,197.3713,309,149.6410,026,978.98
 经营活动现金流入小计(元) 23,765,910.1521,915,622.7619,290,987.59421,644,414.61271,741,437.30
 购买商品、接受劳务支付的现金(元) 17,008,415.3550,375,702.1931,652,528.03254,866,160.44194,568,338.37
 支付给职工以及为职工支付的现金(元) 14,750,707.5629,918,804.6918,700,598.6327,327,638.1215,473,654.61
 支付的各项税费(元) 741,173.5018,636,848.5518,329,690.1215,903,333.328,308,872.23
 支付其他与经营活动有关的现金(元) 8,418,878.8115,776,006.2652,390,778.2126,423,750.0318,901,495.61
 经营活动现金流出小计(元) 40,919,175.22114,707,361.69121,073,594.99324,520,881.91237,252,360.82
 经营活动产生的现金流量净额(元) -17,153,265.07-92,791,738.93-101,782,607.4097,123,532.7034,489,076.48
二、投资活动产生的现金流量
 收回投资收到的现金(元) 30,164,738.0072,568,226.0047,000,000.0031,000,000.00-
 取得投资收益收到的现金(元) 641,450.59314,860.67138,749.24183,311.16-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 69,000.0022,400.00-10,900.00-
 收到其他与投资活动有关的现金(元) --6,208,527.42--
 投资活动现金流入小计(元) 30,875,188.5972,905,486.6753,347,276.6631,194,211.16-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 905,620.008,544,130.027,597,465.1810,581,264.673,826,632.54
 投资支付的现金(元) 24,340,687.0058,001,230.0039,561,230.0088,103,500.00-
 取得子公司及其他营业单位支付的现金净额(元) -995,969.05---
 投资活动现金流出小计(元) 25,246,307.0067,541,329.0747,158,695.1898,684,764.673,826,632.54
 投资活动产生的现金流量净额(元) 5,628,881.595,364,157.606,188,581.48-67,490,553.51-3,826,632.54
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 18,300,000.0014,500,000.0014,500,000.00--
 筹资活动现金流入小计(元) 18,300,000.0014,500,000.0014,500,000.00--
 偿还债务支付的现金(元) 14,500,000.00----
 分配股利、利润或偿付利息支付的现金(元) 196,316.6710,396,777.5210,243,437.23--
 支付其他与筹资活动有关的现金(元) 1,104,489.834,017,780.882,019,073.873,075,020.80-
 筹资活动现金流出小计(元) 15,800,806.5014,414,558.4012,262,511.103,075,020.80-
 筹资活动产生的现金流量净额(元) 2,499,193.5085,441.602,237,488.90-3,075,020.80-
四、汇率变动对现金及现金等价物的影响(元) -712,870.67598,429.89511,148.691,894,867.61562,988.64
五、现金及现金等价物净增加额(元) -9,738,060.65-86,743,709.84-92,845,388.3328,452,826.0031,225,432.58
 加:期初现金及现金等价物余额(元) 17,145,237.63103,888,947.47104,346,444.5775,436,121.4775,436,131.28
 期末现金及现金等价物余额(元) 7,407,176.9817,145,237.6311,501,056.24103,888,947.47106,661,563.86
补充资料:
 净利润(元) -7,332,540.44-47,758,428.526,419,230.0463,191,193.6789,628,894.72
 资产减值准备(元) 1,769,956.3614,091,243.23-3,231,010.2721,838,094.49487,781.78
 固定资产和投资性房地产折旧(元) 1,338,726.352,971,898.061,345,966.721,995,371.00851,378.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,338,726.352,971,898.061,345,966.721,995,371.00851,378.38
 无形资产摊销(元) 140,300.0568,183.47-79,764.5268,930.99
 长期待摊费用摊销(元) 695,554.311,705,382.81605,778.561,053,850.22238,137.00
 处置固定资产、无形资产和其他长期资产的损失(元) 10,793.77-84,904.54--1,268.64-
 公允价值变动损失(元) -11,464.40--11,959.40-
 财务费用(元) 1,002,293.90247,944.88-2,561,188.41-1,178,846.19-3,491,862.19
 投资损失(元) -287,640.39-1,055,944.65--645,360.47-
 递延所得税(元) -1,018,455.27-10,291,226.33391,360.92-7,131,267.56-1,192,396.72
  其中:递延所得税资产减少(元) -1,013,947.64-9,777,428.60417,559.48-7,687,887.75-1,192,396.72
 递延所得税负债增加(元) -4,507.63-513,797.73-26,198.56556,620.19-
 存货的减少(元) -468,150.087,229,995.16-11,006,936.30-23,176,720.032,208,550.50
 经营性应收项目的减少(元) -13,425,468.089,849,903.40-11,566,604.63-20,005,837.15-30,350,490.57
 经营性应付项目的增加(元) -1,392,513.80-87,355,628.03-83,786,504.1220,722,089.54-32,773,216.64
 其他(元) --5,775.73--
 现金的期末余额(元) 7,407,176.9817,145,237.63-103,888,947.47-
 减:现金的期初余额(元) 17,145,237.63103,888,947.47-75,436,121.47-
 现金及现金等价物的净增加额(元) -9,738,060.65-86,743,709.84-92,845,388.3328,452,826.0031,225,432.58
公告日期 2024-08-272024-04-152023-08-292023-04-272022-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院